David Vroman, MD
Ophthalmology · Ladson, SCNPI 1750393138
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.9%), food and beverage and other — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Alcon Research LLC at 41.7% of the total. 2025 is the largest year on record at $27,258, 9.1 times the $3,005 reported in 2019. Among ophthalmology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 434 payments — averaging $140.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$25K
- Glaukos Corporation$21K
- Alcon$3K
- Biotissue Holdings Inc.$2K
- Dompe US, Inc.$1K
- Bausch & Lomb Americas Inc.$977
- plus $7K from 28 others
Across 73 payments — averaging $1462.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Avedro Inc.$47K
- Glaukos Corporation$37K
- Johnson & Johnson Surgical Vision, Inc.$13K
- Alcon Research LLC$9K
What the payments were for
- Consulting fees$32,18853%
- Speaking & faculty fees$1,2002%
- Travel & lodging$4,7468%
- Food & beverage$15,26825%
- Gifts$190%
- Other$7,47512%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 14 | $25,418 |
| Glaukos Corporation | 24 | $20,959 |
| Alcon | 89 | $3,275 |
| Biotissue Holdings Inc. | 31 | $2,264 |
| Dompe US, Inc. | 10 | $1,364 |
| Bausch & Lomb Americas Inc. | 32 | $977 |
| AbbVie(2 entities) | 24 | $817 |
| Harrow Eye, LLC | 15 | $768 |
| Ocular Therapeutix, Inc. | 31 | $744 |
| Sun Pharmaceutical Industries Inc. | 44 | $645 |
| Rxsight Inc | 13 | $554 |
| Novartis | 12 | $406 |
| Oyster Point Pharma, Inc. | 13 | $335 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $291 |
| Johnson & Johnson Surgical Vision, Inc. | 7 | $260 |
| Kala Pharmaceuticals, Inc. | 14 | $236 |
| Omeros Corporation | 8 | $189 |
| Rayner Intraocular Lenses Limited | 9 | $175 |
| NEW World Medical,inc. | 2 | $173 |
| Mallinckrodt Hospital Products Inc. | 3 | $139 |
| Tarsus Pharmaceuticals, Inc. | 5 | $134 |
| Avedro Inc. | 1 | $126 |
| Sight Sciences, Inc. | 1 | $123 |
| Aerie Pharmaceuticals, Inc. | 7 | $107 |
| Shire North American Group Inc | 5 | $106 |
| Staar Surgical Company | 1 | $95 |
| Amgen(2 entities) | 4 | $71 |
| Carl Zeiss Meditec, Inc. | 1 | $36 |
| Eyevance Pharmaceuticals LLC | 1 | $25 |
| Akorn, Inc. | 1 | $23 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Ivantis, Inc | 1 | $16 |
| Spinal Simplicity, LLC | 1 | $14 |
| Merz Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epioxa$8,337
- Travoprost Intraocular Implant - iDose$2,863
- CE-marked KXLA system$1,422
- Oxervate$1,200
- Photrexa Viscous and Photrexa$379
- DEXTENZA$369
- KXL System$358
- XIIDRA$349
- Clareon$286
- AcrySof$279
- VEVYE$233
- MIEBO$233
- AcrySof IQ PanOptix$227
- AIR OPTIX$156
- Photrexa$153
- Unity$142
- IHEEZO$141
- ORA$139
- LenSx$136
- XEN GLAUCOMA TREATMENT SYSTEM$135
How this compares
$60,896 in reported general payments places this provider in the 95th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 54 | $72,556 |
| Loteprednol Etabonate | 260 | $38,121 |
| Prednisolone Acetate | 655 | $31,288 |
| XiidraLifitegrast | 21 | $30,449 |
| Cyclosporine | 36 | $24,961 |
| CombiganBrimonidine Tartrate/Timolol | 32 | $13,026 |
| MieboPerfluorohexyloctane/Pf | 13 | $9,735 |
| Lotemax SmLoteprednol Etabonate | 17 | $6,203 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 42 | $6,032 |
| ProlensaBromfenac Sodium | 17 | $5,998 |
| MoxifloxacinMoxifloxacin Hcl | 263 | $5,772 |
| ValacyclovirValacyclovir Hcl | 102 | $4,691 |
| LumiganBimatoprost | 11 | $4,472 |
| Bromfenac Sodium | 25 | $4,386 |
| Latanoprost | 69 | $1,018 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Combigan, Lumigan | $817 | $90,05397 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate, Lotemax Sm, Prolensa | $291 | $50,323294 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $977 | $40,18334 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 293 ophthalmology providers in South Carolina.
Other ophthalmology in Ladson
- Kristiana NeffLadson$23K
- Millin BudevLadson$16K
- John ThompsonLadson$13K
- Rachel EllynLadson$11K
- Phelan PiehotaLadson$10K
- Michelle YingLadson$7K
- Kerry SolomonMt Pleasant$1.7M
- William ClarkWest Columbia$768K
- George WaringMt Pleasant$645K
- Karolinne RochaCharleston$552K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.